Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma
Blood Adv
.
2026 Feb 24;10(4):1405-1408.
doi: 10.1182/bloodadvances.2025018655.
Authors
Hira Mian
1
,
Mariano Arribas
2
,
Rafael Fonseca
2
,
Erin Mutterback
3
,
Omar Shahid
1
,
Rohan Gouda
1
,
Gregory R Pond
1
,
Alissa Visram
1
Affiliations
1
Department of Oncology, McMaster University, Hamilton, ON, Canada.
2
Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.
3
Department of Hematology, University of Ottawa, Ottawa, ON, Canada.
PMID:
41411522
PMCID:
PMC12927043
DOI:
10.1182/bloodadvances.2025018655
No abstract available